-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Tenofovir Disoproxil USP Related Compound B
Category | Hepatitis B Virus (HBV) |
CAS | 1446486-33-4 |
Description | Tenofovir Disoproxil USP Related Compound B is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. |
Product Information
Synonyms | (E)-9-(Prop-1-enyl)-9H-purin-6-amine; USP Tenofovir Disoproxil Related Compound B; Tenofovir Disoproxil Related Compound B; 9H-Purin-6-amine, 9-(1E)-1-propen-1-yl-; 9-(1E)-1-Propen-1-yl-9H-purin-6-amine; Mutagenic Impurity of Tenofovir Disoproxil; (E)-9-(Prop-1-en-1-yl)-9H-purin-6-amine; 9-Propenyladenine |
IUPAC Name | 9-[(E)-prop-1-enyl]purin-6-amine |
Molecular Weight | 175.19 |
Molecular Formula | C8H9N5 |
Canonical SMILES | CC=CN1C=NC2=C(N=CN=C21)N |
InChI | InChI=1S/C8H9N5/c1-2-3-13-5-12-6-7(9)10-4-11-8(6)13/h2-5H,1H3,(H2,9,10,11)/b3-2+ |
InChIKey | ACWCANXGLNLMJB-NSCUHMNNSA-N |
Boiling Point | 415.6±48.0°C at 760 mmHg |
Melting Point | 143-145°C |
Flash Point | 205.2±29.6 °C |
Purity | ≥98% |
Density | 1.39±0.1 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | White to Off-white Solid |
Storage | Store at -20°C |
Complexity | 205 |
Exact Mass | 175.085800 |
Index Of Refraction | 1.715 |
Target | HIV |
Vapor Pressure | 0.0±1.0 mmHg at 25°C |
XLogP3-AA | 0.8 |